51 results
Page 3 of 3
424B5
89abls7mxni2yg
13 Sep 18
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
f0zaknfqaf 944
13 Sep 18
MorphoSys and Galapagos announce U.S. Antitrust Clearance for global license agreement for MOR106 with pharma partner
12:00am
6-K
EX-99.2
9s6ovpcd6o6dc9jmwcj3
2 Aug 18
Current report (foreign)
4:03pm
6-K
EX-99.1
opgyb
19 Jul 18
Current report (foreign)
6:05am
6-K
EX-99.1
5j8tokw mj70
27 Jun 18
Servier and Galapagos announce start of global ROCCELLA Phase 2 clinical trial with S201086/GLPG1972 in osteoarthritis patients
6:01am
6-K
EX-99.1
ig5usg6
2 May 18
Galapagos and MorphoSys announce initiation of the IGUANA Phase 2 clinical trial with MOR106 in atopic dermatitis patients
6:00am
6-K
EX-99.2
33pix tahe
27 Apr 18
Galapagos reports first quarter 2018 results
12:00am
20-F
24aktpkcifh4p1
25 Mar 16
Annual report (foreign)
12:00am
DRS
dt4y5lzhvnmmv4l8c9q
6 Feb 15
Draft registration statement
12:00am